PET Drug
- 18F-fludeoxyglucose (FDG)
- 13N-ammonia
- 68Ga-Gozetotide
- 18F-choline (FCh)
- 18F-fluoroethyltyrosine (FET)
- 18F-FDOPA
- 11C-D-Methionine
- 11C-Nicotine
- 11C-Carfentanil
- 11C-YJH08
- 18F-FAraG
- 18F-CTT1057
- 18F-FAZA
- 68Ga-FAP2286
- 64Cu-FAP2286
- 68Ga-Citrate
- 89Zr-YS5
- 89Zr-VRC01
- 89Zr-Cimzia
- 18F-RP115
- 64Cu-GRIP-B
Mechanism
- Glucose metabolism
- Cardiac perfusion
- Prostate specific membrane antigen
- Metabolism/Parathyroid adenoma
- Brain tumors
- Dopaminergic pathway
- Amino acid kinetics
- Tobacco research
- Opioid receptor agent
- Glucocorticoid receptor
- Activated T-cells
- Prostate specific membrane antigen
- Hypoxia
- Fibroblast activated protein
- Fibroblast activated protein
- Tumor imaging
- CD46 imaging
- HIV viral coat protein
- TNF-alpha
- Excitatory amino acid transporter 2
- Granzyme-B
Cyclotron Contact
Robin Cumming, PhD
Director
Ph: (415) 353-4476
robin.ippisch@ucsf.edu
